Latest News

Date Title Topic
24 Jun 2013 A Novel Agent, Ibrutinib, Shows Potential as a Safe, Effective, Targeted Treatment Haematologic malignancies - Anticancer agents & Biologic therapy
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
18 Jun 2013 EMUC 2013 Press Release: From Guidelines to Personalised Medicine 5th EMUC Examines Personalised Therapies for Urological Cancers Genitourinary cancers
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine - Translational research
13 Jun 2013 First-line Treatment Strategies for Advanced-Stage Follicular Lymphoma: Which is The Best One? Haematologic malignancies
Melanoma
06 Jun 2013 European Medicines Agency recommends granting a marketing authorisation for lipegfilgrastim Palliative and supportive care - Anticancer agents & Biologic therapy
05 Jun 2013 Bevacizumab: The First Agent to Remarkably Improve Survival in Recurrent Cervical Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
04 Jun 2013 European Medicines Agency recommends approval of pomalidomide Haematologic malignancies - Anticancer agents & Biologic therapy
03 Jun 2013 FDA Approves Trametinib and Dabrafenib for Unresectable or Metastatic BRAF-Mutated Melanoma Melanoma - Anticancer agents & Biologic therapy
17 May 2013 Cisplatin-Based Chemoradiation: In Which Setting(s) Could Cisplatin Replace Mitomycin in the Treatment of Localised Anal Squamous Cell Carcinoma? Gastrointestinal cancers
14 May 2013 EU funded CAMINEMS project combines three emerging technologies – nanotechnology, optical technologies, and microfluidics Translational research
11 May 2013 EMCTO 2013 News: Initial results from the largest prospective study of pulmonary metastasectomy in patients with colorectal cancer Lung and other thoracic tumours
11 May 2013 EMCTO 2013 News: Stereotactic ablative radiotherapy is an effective alternative in patients with multiple primary lung cancers Lung and other thoracic tumours
Certificate of Attendance